CD19-specific CAR T Cells With a Fully Human Binding Domain for CD19+ Leukemia or Lymphoma
Clinical trial NCT03684889 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03684889
- Sponsor
- Seattle Children's Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-28
- Primary completion
- 2021-02-08
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.